Understanding fertility begins with evaluating the hormonal profile. The Anti-Müllerian Hormone blood test, known as AMH, provides useful information about the number of eggs remaining in the ovaries. It can be performed on any day of the cycle and is often the first step for women who want a clearer view of their reproductive timeline.

 

On its own, AMH offers an indication of egg quantity but not the full picture. For a more objective assessment, results are usually combined with an ovarian ultrasound and the antral follicle count, known as AFC (antral follicle count). Together, these measurements allow doctors to evaluate ovarian reserve with greater accuracy.

 

As age increases, egg reserves naturally decline. Knowing your levels allows timely planning and personalized decisions. For some women, the findings are reassuring. For others, they may lead to a discussion about fertility preservation through egg freezing, protecting today’s reproductive potential for the future.

 

Rather than relying on assumptions, decisions can be based on data. A blood test together with an ultrasound scan can turn uncertainty into a clear plan.

 

For more information about AMH testing and AFC, the medical team can guide you through the process and discuss the options available.